Heartflow, Inc. (HTFL)
Nasdaq: HTFL · Surgical & Medical Instruments & Apparatus · Mountain View, CA · filing with the SEC since 2009
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 |
| Report filed | Mar 18, 2026 | · | · |
| Revenue | 176,034 | 125,808 | 87,174 |
| Cost of revenue | 40,837 | 31,359 | 29,123 |
| Gross profit | 135,197 | 94,449 | 58,051 |
| Research and development | 64,918 | 43,517 | 35,854 |
| Selling, general and administrative | 134,345 | 112,154 | 95,111 |
| General and administrative | 39,490 | 30,789 | 31,788 |
| Total operating expenses | 199,263 | 155,671 | 130,965 |
| Operating income | -64,066 | -61,222 | -72,914 |
| Interest expense | 15,173 | 22,768 | 24,694 |
| Interest and investment income | 5,538 | 4,066 | 5,457 |
| Other income (expense), net | -223 | 168 | 325 |
| Total non-operating income (expense) | -52,801 | -35,151 | -22,194 |
| Income before income taxes | -116,867 | -96,373 | -95,108 |
| Income tax expense | -76 | 53 | 547 |
| Net income | -116,791 | -96,426 | -95,655 |
| Net income to common shareholders | -116,791 | -96,426 | -123,688 |
| Earnings per share, basic | -3.17 | -17.98 | -25.32 |
| Earnings per share, diluted | -3.17 | -17.98 | -25.32 |
| Weighted average shares, basic | 36,853,867 | 5,363,435 | 4,885,231 |
| Weighted average shares, diluted | 36,853,867 | 5,363,435 | 4,885,231 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfRevenueGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperatingInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding